Precision Optics Corporation, Inc.

NASDAQ:POCI

Medical - Instruments & Supplies

Healthcare
$4.87 +3.03%

+$0.14 today

Market cap
$53.44M
Beta
0.32
P/E (TTM)
-6.9
EPS (TTM)
-$0.63
52W Low $3.55High $6.15

Volume 0.03M

Average 0.05M

POCI Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

Precision Optics Corporation, Inc.NASDAQ: POCI

Research & Development · Q3 FY2026 · quarter ended Mar 2026

Research & development growth accelerates

Q3 FY2026 research & development of $267.32K rose 26.5% year over year, ahead of the -17.7% change in trailing-twelve-month research & development. Sequentially, it rose 7.1% from the prior quarter. Over 3 fiscal years it compounded at +20.2% a year.

Context

  • Research & development amounted to 6.1% of revenue in FY2025, up 0.9 pp from a year earlier.
  • Research & development increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +26.5% holds above the trailing-twelve-month pace of -17.7%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$267.32K+7.1% QoQ
Last fiscal yearJun 2025
$1.16M+17.9% YoY
LTMMar 2026
$1.06M-17.7% YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+26.5%——
1 year+17.9%——
3-year CAGR+20.2%——
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
1.16M USD
Year-over-year change
+17.9%
4-year CAGR
+16.7%

Research & Development vs competitors

How POCI compares with its peers on the latest reported figures

  • POCI's LTM Mar 2026 research & development of $1.06M is the lowest of the 3 companies compared; the peer median is $4.12M.
  • Its year-over-year change of -17.7% is the 2nd highest of 3, against a peer median of -13.8%.
  • Research & development amounts to 3.7% of revenue for POCI, versus a peer median of 48.6%.
POCI Competitors Peer median
Research & Development for POCI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MYOMyomo, Inc.LTM Mar 2026$6.78M +20.9%+40.9%16.4%
NTRBNutriband Inc.LTM Apr 2026$1.45M -48.6%+24.4%80.7%
POCIPrecision Optics Corporation, Inc.LTM Mar 2026$1.06M -17.7%+20.2%3.7%
Peer median (excluding POCI) $4.12M-13.8%+32.7%48.6%

Competitors are the stored peer set for POCI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Jun 2021
FY2022
Jun 2022
FY2023
Jun 2023
FY2024
Jun 2024
FY2025
Jun 2025
Revenue10.67M15.68M21.04M19.1M19.09M
Cost of Revenue7.24M10.75M13.31M13.31M15.69M
Gross Profit3.43M4.93M7.73M5.8M3.4M
Gross Margin32.2%31.4%36.8%30.3%17.8%
Research & Development624.25K666.48K992.38K981.78K1.16M
Selling, General & Admin3.71M5.61M7.38M7.54M7.8M
Operating Expenses4.34M6.28M8.37M8.52M8.96M
Depreciation & Amortization146.8K245.24K210.74K212.38K212.44K
EBITDA50.18K(526.57K)286.99K(2.51M)(5.34M)
EBITDA Margin0.5%-3.4%1.4%-13.1%-28.0%
Operating Income(905.58K)(1.35M)(638.55K)(2.72M)(5.55M)
Operating Margin-8.5%-8.6%-3.0%-14.3%-29.1%
Interest Income00000
Interest Expense5.3K155.66K218.93K225.11K227.02K
Other Income / Expenses803.66K586.43K495.87K(225.11K)(227.02K)
Income Before Tax(101.92K)(927.46K)(142.68K)(2.95M)(5.78M)
Pre-Tax Margin-1.0%-5.9%-0.7%-15.4%-30.3%
Income Tax Expense9129521.94K1.94K1.94K
Net Income(102.84K)(928.42K)(144.61K)(2.95M)(5.78M)
Net Margin-1.0%-5.9%-0.7%-15.4%-30.3%
EPS (Basic)(0.02)(0.18)(0.03)(0.49)(0.85)
EPS (Diluted)(0.02)(0.18)(0.03)(0.49)(0.85)
Weighted Avg Shares4.43M5.3M5.67M6.07M6.79M
Weighted Avg Shares (Diluted)4.43M5.3M5.67M6.07M6.79M

Precision Optics Corporation, Inc.

NASDAQ:POCI

Intrinsic Alpha fair value

Locked

Current Price

$4.87

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.